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Background:
Cerebrovascular disease is a serious complication in sickle cell disease (SCD) associated with a high degree
of morbidity and mortality. The utility of transcranial doppler (TCD) ultrasound to measure velocity within
major arteries of the brain has been validated as a way to predict those at increased risk for stroke.
Hemolysis via a hemolytic index variable has been shown to be associated with complications associated
with SCD.

Objectives/Goal:
This study aimed to evaluate an association between a hemolytic index variable (HI) obtained in the first
two years of life and development of abnormal or conditional TCD velocities later in childhood in patients
with sickle cell anemia (SCA) with thoughts this may provide an earlier tool to determine those who may be
at increased risk for stroke prior to either obtaining a TCD or developing an abnormal TCD. The study also
aimed to evaluate for an association between HI with other SCD related acute complications, i.e.
hospitalization, stroke, acute chest syndrome (ACS)

Methods/Design:
This study was a single-center, retrospective chart review of patients with SCA receiving their disease
related care at our center over a 17 year period. Laboratory values, including lactate dehydrogenase (LDH),
aspartate aminotransferase (AST), total bilirubin (TB), absolute reticulocyte count (ARC), and hemoglobin
(HB), obtained in the first two years of life were extracted; these values were utilized to calculate a

hemolytic index (HI) via principle component analysis. All TCD results and complication history from 2-21
years of age were also extracted from the patient’s record. Cox proportional hazards models were then used
to determine if the hemolytic index was a risk factor the above.

Results:
A total of 109 patients were included in the analysis revealing Cox regression hazards model utilizing HI
revealed a hazard ratio of 1.33 (95% CI 1.04‐1.70, p = 0.025) for developing a conditional or abnormal TCD
velocity. HB was then included along with the other four laboratory values for principle component analysis
in creation of a hemoglobin HI (HHI) with Cox regression hazards model utilizing HHI revealed a hazard
ratio of 1.31 (95% CI 1.04‐1.66, p = 0.024). HI was then evaluated as a predictor for development of stroke
or ACS revealing a hazard ratio of 1.21 (95% CI 0.82-1.79, p = 0.345) for stroke and a hazard ratio of 1.28
(95% CI 1.04-1.58, p=0.022) for ACS.

Conclusions:
This retrospective study noted an increased risk for development of an abnormal or conditional TCD with an
increased HI. The addition of hemoglobin to the HI to form HHI showed an elevated risk for abnormal or
conditional TCD to the same degree as HI itself. These results could offer an additional tool in the evaluation
of the pediatric SCA population, although these results would benefit from a prospective look. Further look
into a possible association between HI and other SCD related complications such as stroke and acute chest
syndrome could provide further information for the treating team for the overall management of this
complex disease.

